Plus3D Secures RMB 200 Million Series C Funding to Accelerate Industrialization of 3D Printing

VCBeat has learned at the earliest opportunity that China's leading3D Printing Digital Application Solutions Provider——Shanghai Prismlab Mechatronics Technology Co., Ltd.(hereinafter referred to as“Prismlab”) announced the completion ofRMB 200 millionofSeries CFinancing. This round of financing was led byQiming Venture PartnersLead Investor, Existing ShareholdersBASF Venture CapitalandJinyu Maowu Investment ManagementCo-investment,Multidimensional CapitalServe as the exclusive financial advisor.

The proceeds from this financing round will be primarily used to further expand the company’s domestic and international operations, including upgrading and iterating existing product lines, expanding manufacturing facilities, recruiting talent in micro- and nano-scale 3D printing, and developing new technologies. These initiatives aim to enhance the company’s technological capabilities and strengthen its leading position in the digital application sector of the 3D printing industry.

Founded in 2005, Prismlab has carved out a unique position in the dental healthcare sector with its benchmark solutions in orthodontics and a complete application loop for digital dentistry. Leveraging its strengths in 3D printing, Prismlab has launched a comprehensive solution for clear aligners centered around 3D printing equipment. This solution covers the entire industry chain for clear aligner production, from 3D printing and orthodontic membrane materials to automated thermoforming and cutting, thereby establishing a full-scale manufacturing and processing system for clear aligners. Currently, this solution has become the preferred choice for domestic clear aligner companies in China, capturing over 60% of the market share.

Meanwhile, Prismlab has been actively developing its digital denture system. Since 2020, the company has deeply engaged in the denture manufacturing industry, leveraging its product features and extensive experience in 3D mass production to launch a comprehensive digital manufacturing framework for dental laboratories. This initiative promotes the transition of denture processing towards intelligent, digitalized production. By further integrating additive manufacturing with smart manufacturing, Prismlab helps enterprise clients more effectively achieve their digital transformation goals, reducing costs and improving efficiency. This business line has gained recognition from leading customers across major regions in China, serving hundreds of industry clients.

Currently, Prismlab offers a range of 3D printing equipment for various applications, as well as multiple custom resin materials co-developed with the global chemical giant BASF. Integrating R&D, sales, and services, the company markets its products in more than 50 countries and regions worldwide.

As early as 2013, Prismlab successfully developed its Sub-pixel Micro-scanning (SMS) technology, which features internationally leading performance and independent intellectual property rights. This technology was successfully applied in the development of large-format stereolithography (SLA) 3D printers, effectively overcoming the technical challenge of simultaneously achieving large build volume, high speed, and high precision. As a result, while meeting stringent accuracy requirements, the printing efficiency of 3D printing equipment was significantly enhanced, making it technically feasible to integrate 3D printing into industrial-scale production.

Leveraging its technological expertise in 3D printing, Prismlab has developed the “Rapid” series of 3D printers and compatible materials. Distinguished by significant advantages including fast build speeds, large build volumes, high printing precision, and low overall costs, these products have gained strong customer preference and rapidly propelled Prismlab into the ranks of leading 3D printer manufacturers.

Technological innovation is the inexhaustible driving force behind Prismlab’s development. The company has secured dozens of core technology patents and, in the past five years, has led the completion of major domestic research projects, including the “National Key R&D Program: Additive Manufacturing Processes and Equipment for Micro-Nano Structures” and the “Intelligent Dental 3D Printing Service Project.” Prismlab has been successfully included in the lists of “Shanghai Specialized, Refined, Differential, and Innovative Enterprises” and the “Shanghai Little Giants Cultivation Project,” becoming one of the few 3D printing companies in China that closely integrates technological innovation with industrial commercialization. Leveraging its technical expertise in the field of 3D printing, Prismlab spearheaded a key national R&D program under the Ministry of Science and Technology and launched the MP series of micro-nano 3D printing equipment, which holds international patents and features more advanced technology. The printing efficiency of these devices is hundreds of times higher than that of similar products in the industry.

In the future, the company will focus on developing applications of microfluidics and micro-nano printing in areas such as microfluidic chips, microdevices, precision medical instruments, and micro-nano ceramic microstructural components. It will further increase R&D investment in the micro-nano field and expand its related business teams to strengthen its core competitiveness and meet the technological demands of the micro-nano 3D sector.

At the policy level, since 2012, multiple Chinese government departments have successively introduced industrial policies for 3D printing, elevating the development of the 3D printing industry to a national strategic level. Prismlab has actively responded to national policies, grounding itself in the present while looking toward the future. It has been actively exploring technological innovation and digital industrial applications, gradually attracting external attention. With the support of renowned enterprises and investment institutions such as BASF, SABIC (a Fortune Global 500 company), Jinyu Maowu Investment Management, Linsong Venture Capital, Aowen Venture Capital, Founder Hezheng, and Hengyi Digital, Prismlab has seized this favorable momentum and officially entered a phase of rapid growth.

Hou Feng, Founder and CEO of PrismlabPrismlab stated: “Rooted in 3D printing-related technical services, Prismlab focuses on leveraging digital and mass-production capabilities of 3D printing to address a range of application challenges, with the corporate goal of becoming the world’s leading brand in commercial 3D printing applications. With the support of prominent investors such as Qiming Venture Partners and BASF, Prismlab is poised to unlock greater potential and progressively implement its 3D printing initiatives. The company will concentrate on more technically demanding and advanced niche fields, such as micro- and nano-scale 3D printing, to promote the widespread adoption of commercial 3D printing applications and strive to become an internationally leading 3D printing service provider.”

Lead Investor in This RoundHu Xubo, Managing Partner at Qiming Venture Partnersstated: “Prismlab is a leading provider of industrial 3D printing solutions in China. It pioneered 3D printing equipment capable of continuous, mass production, and its orthodontics business has maintained the industry’s top position for many years, becoming the exclusive supplier to multiple clear aligner manufacturers. Furthermore, the company plays a significant role in the industrial application of digital healthcare services and intelligent manufacturing, helping more enterprise clients achieve digital transformation. We look forward to Prismlab continuing to drive innovation and R&D in traditional 3D printing, micro-nano 3D printing, and precision manufacturing, guided by technology and market demands, thereby supporting the transformation and upgrading of China’s manufacturing sector and delivering high-quality services to global customers.”

Qin Han, Head of BASF Venture Capital ChinaHe stated, “Prismlab was BASF Venture Capital’s first direct investment enterprise in China in 2018, and we have maintained a close partnership for nearly four years. As an industrial investor, it is our honor to have witnessed Prismlab’s growth over the past few years. The company has not rested on its laurels but has consistently risen to challenges, consolidating its leading position in the core orthodontics business while extending its industrial chain and successfully expanding into other applications within the medical dental field. This demonstrates the professionalism and execution capabilities of its management team. Moving forward, we will continue to provide industrial resources centered around Prismlab’s core technologies and businesses, looking forward to seeing the company achieve faster development and greater accomplishments in the field of micro-nano additive manufacturing.”

Li Hongsen, Partner at Jinyu Maowu Investment Managementstated: “Prismlab represents Jinyu Maowu’s strategic investment in the upstream sector of the dental industry. By relying entirely on its own technological breakthroughs, the company has introduced the innovative service concept of ‘addressing personalized needs through industrialized methods’ and successfully implemented it in practical product applications. In the highly personalized scenario of 3D printing for clear aligner orthodontics, Prismlab provides continuous, mass-scale digital services, effectively reducing various costs for client enterprises and breaking through the bottleneck of production efficiency in dental digitization. From a long-term perspective on industry development, we support Prismlab’s business model and are optimistic about its future prospects.”

Zhou Xuan, Founding Partner of Duowei Capitalstated: “The 3D printing industry has long faced a trade-off among print quality, precision, and speed. Prismlab’s self-developed sub-pixel micro-scanning technology perfectly addresses the most significant pain point of traditional 3D printing. This enables Prismlab to achieve both large build volumes and high precision of 2 μm, along with high production efficiency. With this round of financing, we can rapidly advance the application and market promotion of our platform-based core technologies in the field of micro- and nano-additive manufacturing.”